140 related articles for article (PubMed ID: 6307500)
1. The treatment of cancer patients with human lymphoblastoid interferon. A comparison of two routes of administration.
Knost JA; Sherwin SA; Abrams PG; Ochs JJ; Foon KA; Williams R; Tuttle R; Oldham RK
Cancer Immunol Immunother; 1983; 15(2):144-8. PubMed ID: 6307500
[TBL] [Abstract][Full Text] [Related]
2. Changes in immune function in patients receiving natural leukocyte interferon.
Maluish AE; Ortaldo JR; Sherwin SA; Oldham RK; Herberman RB
J Biol Response Mod; 1983; 2(5):418-27. PubMed ID: 6644346
[TBL] [Abstract][Full Text] [Related]
3. [Clinical effect of human lymphoblastoid interferon in patients with multiple myeloma].
Yoshida M; Ohta M; Muroi K; Takeda K; Kitagawa S; Tsuboyama A; Sakamoto S; Miura Y; Mutoh Y
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1394-8. PubMed ID: 6742866
[TBL] [Abstract][Full Text] [Related]
4. [Phase I study of human lymphoblastoid alpha-interferon on malignant tumor].
Furue H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):977-83. PubMed ID: 3963861
[TBL] [Abstract][Full Text] [Related]
5. [Comparative clinical study of single and combination therapy of human lymphoblastoid interferon (HLBI) with 5-FU in the treatment of advanced renal cell carcinoma].
Asakawa M; Maekawa T; Umeda M; Sakamoto W; Senju M; Iseki T; Nakatani T; Tanaka H; Horii A; Yamamoto K
Hinyokika Kiyo; 1989 Aug; 35(8):1451-5. PubMed ID: 2816609
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of weekly high-dose human lymphoblastoid interferon.
Connors JM; Silver HK
Cancer Treat Rep; 1984 Sep; 68(9):1093-6. PubMed ID: 6478449
[TBL] [Abstract][Full Text] [Related]
7. [Effect of topical injections of native alpha-interferon (HLBI) in the treatment of skin lesions of adult T cell leukemia: report of a case].
Sugie Y; Hayashi S; Shibuya T; Otsuka T; Okamura T; Harada M; Niho Y
Rinsho Ketsueki; 1990 Apr; 31(4):497-501. PubMed ID: 2381068
[TBL] [Abstract][Full Text] [Related]
8. [Clinical trial of human lymphoblastoid interferon on advanced malignancy].
Usui N; Ogawa M; Inagaki J; Horikoshi N; Inoue K; Miyamoto H; Ikeda K; Nakada H; Adachi K; Okada Y
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2324-9. PubMed ID: 6357102
[TBL] [Abstract][Full Text] [Related]
9. The antitumor effects of human lymphoblastoid interferon on human renal cell carcinoma in athymic nude mice.
Yamaoka T; Takada H; Yanagi Y; Kataoka T; Sakurai Y
Cancer Chemother Pharmacol; 1985; 14(3):184-7. PubMed ID: 3995680
[TBL] [Abstract][Full Text] [Related]
10. A phase I study of human lymphoblastoid interferon administered by continuous intravenous infusion.
Rohatiner AZ; Balkwill FR; Griffin DB; Malpas JS; Lister TA
Cancer Chemother Pharmacol; 1982; 9(2):97-102. PubMed ID: 7172412
[TBL] [Abstract][Full Text] [Related]
11. Phase I study of pharmacological and immunological effects of human lymphoblastoid interferon given to patients with cancer.
Laszlo J; Huang AT; Brenckman WD; Jeffs C; Koren H; Cianciolo G; Metzgar R; Cashdollar W; Cox E; Buckley CE; Tso CY; Lucas VS
Cancer Res; 1983 Sep; 43(9):4458-66. PubMed ID: 6603265
[TBL] [Abstract][Full Text] [Related]
12. [Clinical effects of human lymphoblastoid interferon in patients with hematologic neoplasms].
Oda Y; Irie S; Inagaki M; Fukumoto M; Ueda I; Ohmoto E; Fujimoto S; Endo Y; Watanabe S; Lai M; Takahashi I; Kimura I; Ishii H; Sezaki T
Gan To Kagaku Ryoho; 1983 May; 10(5):1313-9. PubMed ID: 6575725
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study on the effect of human lymphoblastoid interferon in multiple myeloma].
Takeyama H; Yano K; Kataoka T; Yamamoto M; Emi N; Kodera Y; Kawashima K; Ohno R; Yokomaku S; Kobayashi M
Gan To Kagaku Ryoho; 1983 Sep; 10(9):2043-8. PubMed ID: 6614939
[TBL] [Abstract][Full Text] [Related]
14. Intratumoural and intraventricular human lymphoblastoid alpha interferon (HLBI) for treatment of glioblastoma multiforme.
Martínez R; Vaquero J; Ramiro J; García Salazar F; De Oya S
Acta Neurochir (Wien); 1989; 100(1-2):46-9. PubMed ID: 2554692
[TBL] [Abstract][Full Text] [Related]
15. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
16. A phase I trial of recombinant leukocyte alpha 2 interferon in patients with advanced malignancy.
Muss HB; Richards F; Homesley HD; Spurr CL; Rudnick SA; Stuart JJ; Plunkett S; Welander C; Caponera M; White DR
Am J Clin Oncol; 1985 Apr; 8(2):97-107. PubMed ID: 3834792
[TBL] [Abstract][Full Text] [Related]
17. Extended phase I study of human beta-interferon in human cancer.
Abdi EA; Kamitomo VJ; McPherson TA; Konrad MW; Inoue M; Tan YH
Clin Invest Med; 1986; 9(1):33-40. PubMed ID: 3955919
[TBL] [Abstract][Full Text] [Related]
18. A simple methodology for the routine production and partial purification of human lymphoblastoid interferon.
Neame PJ; Acton RT
Adv Exp Med Biol; 1984; 172():269-79. PubMed ID: 6328906
[TBL] [Abstract][Full Text] [Related]
19. Modulation of 2',5'-oligoadenylate synthetase in patients treated with alpha-interferon: effects of dose, schedule, and route of administration.
Merritt JA; Ball LA; Sielaff KM; Meltzer DM; Borden EC
J Interferon Res; 1986 Jun; 6(3):189-98. PubMed ID: 3745984
[TBL] [Abstract][Full Text] [Related]
20. [Clinical trial of a combination of human lymphoblastoid interferon (HLBI), melphalan and prednisolone (HLBI-MP) in multiple myeloma].
Hara M; Nakamura T; Fujii Y
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1338-41. PubMed ID: 3579331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
